The UK government is embarking on yet another effort to secure supplies of critical medicines and medical products after Brexit, this time in the form of a £25m contract to provide an express freight service able to rapidly deliver small consignments to the UK if normal supply channels are disrupted, as is widely expected in the event of a no-deal exit.
UK Takes More Action To Fly In No-Deal Brexit Drug Supplies
In the latest move in its no-deal Brexit preparations, the UK is offering a contract for suppliers to provide an “uninterrupted supply of medicines and medical products,” including temperature controlled and time-sensitive medicines.
More from United Kingdom
Non-Submissions To UK HTA Body Could Increase Unless Commercial Environment Improves, Warns Industry
• By
Finding ways to lower the rebates paid by the pharmaceutical industry to the UK government and fostering partnerships to make the UK a more attractive launch market could help reduce the number of terminated technology appraisals conducted by NICE, the health technology appraisal institute, says the UK pharmaceutical industry.
• By
Blood cancer therapies were most proportionately impacted by the failure of pharmaceutical companies to submit evidence on their cancer therapies to England’s health technology appraisal body, shows analysis by the Pink Sheet.
• By
The policy expectation that the model clinical trial agreements are used without modification is in line requests from industry and the NHS/HSC.
• By
Efforts by the medicines regulator, the MHRA, to clear all backlogs relating to its statutory functions and maintaining predictable review timeframes have put pressure on its staff.